4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-25-035755
Chief Financial Officer sold 58,400 shares at an average $102.67 ($5,996,094)
- Chief Financial Officer acquired 47,888 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bonstein Sara · Chief Financial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-07-21 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,443 | $26.46 | $91,102 | 87,460 | D |
| 2025-07-21 | Exercise or conversion : show line 2 in the form 10b5-1 | +11,455 | $28.88 | $330,820 | 98,915 | D |
| 2025-07-21 | Exercise or conversion : show line 3 in the form 10b5-1 | +15,890 | $29.13 | $462,876 | 114,805 | D |
| 2025-07-21 | Exercise or conversion : show line 4 in the form 10b5-1 | +17,100 | $34.03 | $581,913 | 131,905 | D |
| 2025-07-21 | Sale : show line 5 in the form 10b5-1 | −32,090 | $102.38 | $3,285,374 | 99,815 | D |
| 2025-07-21 | Sale : show line 6 in the form 10b5-1 | −26,310 | $103.03 | $2,710,719 | 73,505 | D |
| Open-market sales · 58,400 sh · avg $102.67 · $5,996,094 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-07-21 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) | −3,443 | 8,580 | D |
| 2025-07-21 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (right to buy) | −11,455 | 0 | D |
| 2025-07-21 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (right to buy) | −15,890 | 47,670 | D |
| 2025-07-21 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option (right to buy) | −17,100 | 0 | D |
Loading xslF345X05/wk-form4_1753302879.xml…